Sharyn A Roodenburg
Overview
Explore the profile of Sharyn A Roodenburg including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
26
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hartman J, Bakker J, Roodenburg S, Klooster K, Slebos D
Lung
. 2025 Jan;
203(1):21.
PMID: 39755853
No abstract available.
2.
Bakker J, Dudurych I, Roodenburg S, Vonk J, Klooster K, De Bruijne M, et al.
Eur Radiol
. 2024 Oct;
PMID: 39414656
Introduction: Lung hyperinflation, a key contributor to dyspnea in chronic obstructive pulmonary disease (COPD), can be quantified via chest computed tomography (CT). Establishing reference equations for lobar volumes and total...
3.
Roodenburg S, van Dijk M, Augustijn S, Klooster K, Slebos D, Hartman J
ERJ Open Res
. 2024 Oct;
10(3).
PMID: 39371297
Background: Assessment of static hyperinflation severity is crucial to identify COPD patients eligible for lung volume reduction. The current recommendation of residual volume ≥175% predicted may need to be reconsidered...
4.
Roodenburg S, Klooster K, Hartman J, Kontogianni K, Brock J, Dittrich A, et al.
Respiration
. 2024 Sep;
104(1):58-68.
PMID: 39284292
Introduction: Currently, there is a lack of bronchoscopic lung volume reduction options that do not depend on fissure integrity. Endobronchial coils have been extensively studied to address this need but...
5.
Roodenburg S, Hartman J, Eichhorn I, Slebos D, Pouwels S
ERJ Open Res
. 2024 Jul;
10(4).
PMID: 39010886
Introduction: Damage-associated molecular patterns (DAMPs) are endogenous danger signals that alert and activate the immune system upon cellular damage or death. It has previously been shown that DAMP release is...
6.
Roodenburg S, Slebos D
Ann Am Thorac Soc
. 2024 Apr;
21(8):1214-1216.
PMID: 38656818
No abstract available.
7.
Roodenburg S, Klooster K, Slebos D, Hartman J
ERJ Open Res
. 2023 Aug;
9(4).
PMID: 37650092
Background: Lung volume reduction with endobronchial valves can significantly improve functional outcomes in patients with advanced emphysema. The extent and spatial distribution pattern of emphysema shows considerable heterogeneity, which might...
8.
Hartman J, Roodenburg S, van Dijk M, Koster T, Klooster K, Slebos D
ERJ Open Res
. 2023 Jul;
9(4).
PMID: 37465561
Background: Bronchoscopic lung volume reduction using endobronchial valves (EBV) has been shown to be beneficial for severe emphysema patients. The most important predictor of treatment response is absence of collateral...
9.
Roodenburg S, Pouwels S, Klooster K, Touw D, Slebos D
Respiration
. 2023 May;
102(6):454-457.
PMID: 37231891
Bronchoscopic lung volume reduction using endobronchial valves (EBVs) is a treatment option for patients with severe emphysema. These EBVs are made out of a nitinol mesh covered by a silicone...
10.
Roodenburg S, Slebos D, van Dijk M, Koster T, Klooster K, Hartman J
Respir Med
. 2023 Mar;
210:107175.
PMID: 36858325
Background: Bronchoscopic lung volume reduction using endobronchial valves (EBV) is a treatment option for selected patients with advanced emphysema. The treatment significantly improves pulmonary function, exercise capacity, quality of life,...